Fulltext

Cardiac biomarkers for infarct diagnosis and early exclusion of acute coronary syndrome = Kardiale Biomarker für die Infarktdiagnose und den frühzeitigen Ausschluss eines akuten Koronarsyndroms

Puelacher, C. ; Hillinger, P. ; Wagener, M. ; Müller, C.

In: Herz, 2014, vol. 39, no. 6, p. 668-671

Ajouter à la liste personnelle
    Titre
    • Cardiac biomarkers for infarct diagnosis and early exclusion of acute coronary syndrome
    Titre traduit ()
    • Kardiale Biomarker für die Infarktdiagnose und den frühzeitigen Ausschluss eines akuten Koronarsyndroms
    Auteur
    • Puelacher, C.. Department of Cardiology and Cardiovascular Research Institute Basel, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland
    • Hillinger, P.. Department of Cardiology and Cardiovascular Research Institute Basel, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland
    • Wagener, M.. Department of Cardiology and Cardiovascular Research Institute Basel, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland
    • Müller, C.. Department of Cardiology and Cardiovascular Research Institute Basel, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland
    Type de document
    • Postprint
    Identifiant OAI-PMH
    • oai:doc.rero.ch:325316
    Summary
    The acute coronary syndrome (ACS) represents a diagnostic challenge: on the one hand patients need to be quickly identified to initiate treatment and on the other hand early exclusion of patients without ACS is important to relieve patient stress as well as overcrowded emergency departments. A growing number of biomarkers are becoming available to aid physicians with this task. This review gives an overview of the current research concerning early exclusion with an emphasis on the clinically most important biomarker: cardiac troponin.